Pollution-triggered asthma: how pain sensors in the lungs derail the immune response
Asthma caused by air pollution responds differently to treatment than classic allergic asthma, and now we know why. Pain receptors in the lungs turn out to actively worsen inflammation through a mechanism that operates independently of the well-known immune pathways.
Air pollution, and fine particulate matter in particular, is one of the most important environmental factors that trigger or worsen asthma. But the type of asthma it produces, neutrophilic asthma, responds poorly to standard treatments such as corticosteroids. That has long suggested a different underlying mechanism from the one at work in classic eosinophilic asthma. New research published in eLife points to an unexpected player: nociceptors, the nerve cells that normally signal pain.
In mouse experiments, researchers modelled pollution-aggravated asthma by exposing animals to fine particulate matter (PM2.5) combined with the allergen ovalbumin. Compared with ovalbumin exposure alone, the combination produced stronger neutrophilic inflammation in the lungs. Crucially, when the researchers silenced the nociceptors, either through genetic modification or chemical ablation, that neutrophilic inflammation dropped significantly. The pain sensors were not merely registering tissue damage; they were actively driving the pathological immune response.
The immune system takes its cues from the nervous system
This fits into a growing field of research: neuroimmunology, the study of how the nervous system and the immune system talk to each other. The idea that pain sensors can amplify immune reactions is not new; nociceptors release neuropeptides such as substance P and CGRP that activate immune cells. But the finding that this mechanism specifically contributes to the most severe forms of pollution-related asthma is a more concrete result with real therapeutic implications.
If nociceptors are making neutrophilic inflammation worse, that opens the possibility of targeting this axis therapeutically without broadly suppressing the immune response. Existing drugs that act on nociceptors, such as TRPV1 antagonists, could be worth revisiting in this context. That said, the road from a mouse model to clinical use can take decades.
Why this matters for ageing
Why should you care about this from a longevity perspective? Chronic low-grade inflammation, often called inflammaging, is one of the most robust correlates of accelerated biological ageing. Neutrophilic inflammation plays a role in that process, and at the population level, exposure to air pollution is associated with reduced life expectancy and faster cognitive decline. The mechanism described here sheds light on how environmental stressors can feed chronic inflammatory processes through the nervous system, a connection that has received far too little attention until now.